Viewing Study NCT05379166


Ignite Creation Date: 2025-12-24 @ 4:16 PM
Ignite Modification Date: 2025-12-29 @ 12:19 AM
Study NCT ID: NCT05379166
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2022-03-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome
Sponsor: Uma Borate
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module